Thus, chemerin/CMKLR1 may be promising new targets for the treatment of obesity and its related diseases, and peptides or other substances that affect chemerin/CMKLR1 axis will be used in the future in the treatment of obesity and diabetes [15]. The gene discussed is RARRES2; the disease is obesity due to melanocortin 4 receptor deficiency.